Tuesday, November 27, 2012

Study Shows Estrogen May Prevent Younger Menopausal Women From Strokes

Dr. Enrique Jacome
Estrogen may prevent strokes in premature or early menopausal women, Mayo Clinic researchers say. Their findings challenge the conventional wisdom that estrogen is a risk factor for stroke at all ages. The study was published in the journal Menopause. Researchers combined the results from a recent Mayo Clinic study with six other studies from across the world and found that estrogen is protective for stroke before age 50. That is roughly the average age when women go through menopause.

"We were very surprised because these results were unexpected," says study author Walter Rocca, M.D., an epidemiologist and neurologist at Mayo Clinic. "The old idea that estrogen is always a problem in the brain has to be corrected." Estrogen can be a problem in older women, he explains, but in younger women, estrogen may be important to protect the brain from strokes.

The study has implications for women who experience premature (before age 40) or early menopause (before age 45) from natural causes or from ovary removal. Women in these groups should consider taking estrogen up to approximately age 50 to prevent stroke, Dr. Rocca says.

Ischemic stroke occurs as a result of an obstruction within a blood vessel supplying blood to the brain. According to the American Stroke Association, these types of strokes account for 87 percent of all stroke cases. If you would like to schedule a hormone evaluation, please contact us at (760) 203-5751 for an appointment.


Co-authors of the study include: Brandon Grossardt, M.S.; Virginia Miller, Ph.D.; Lynne Shuster, M.D.; Robert Brown, Jr., M.D. 

www.vivenaturalhormones.com
 

Friday, November 9, 2012

The Difference Between The Effects Of Bioidentical & Synthetic Hormones On Menopause

Dr. Enrique Jacome
Ever since the Women’s Health Initiative studies came to a screeching halt in 2002, hormone replacement therapy (HRT) has garnered a pretty bad rep. The number of women using HRT declined significantly after it was discovered that the combination of hormones that most women were taking (namely progestin and estrogen) increased the likelihood of heart disease, breast cancer, blood clots and stroke.

The main problem with these studies is that they were only focusing on women who used synthetic hormones, such as Premarin, Provera and Prempro. Nearly a decade later, hormone therapy has become more popular among menopausal women, thanks to natural HRT alternatives, like bioidentical hormone replacement therapy (BHRT).

Bioidentical hormones are molecularly identical to the hormones that the body produces naturally.Bioidentical hormones are derived from naturally occurring, plant-based sources, such as soy and yams. There are several advantages when using natural bioidentical hormones, when compared to their synthetic counterpart.

Being that bioidentical hormones are exact replicas of the hormones your body already produces, the body can’t distinguish the supplemented hormones from the ones your body is producing naturally. So when you take a blood test, your total estradiol level reflects both the bioidentical estradiol and the natural estradiol. This makes it easier for your doctor to closely monitor your total levels and adjust your treatment regimen accordingly. Most synthetic hormones are metabolized differently and aren’t visible using standard lab tests.

Another benefit of using bioidentical hormones is that they’re typically not taken orally. Most synthetic forms of HRT are administered orally, in the form of a pill. Instead, bioidentical hormones are compounded in a laboratory and come in the form of creams, gels, pellets or injection (though not common). It’s best to avoid taking hormones orally (bioidentical or not), because it can lead to high blood pressure, weight gain, elevated cholesterol levels and has even been found to bring on sudden bouts of depression in some women.

Perhaps the most alluring of benefits is the fact that each BHRT regimen is individually tailored to meet your specific needs. There is no such thing as a one-size-fits-all treatment when it comes to balancing hormones. Two women of the same age, who follow the same diet and workout routine, could have wildly different hormone levels. Bioidentical hormones are custom compounded based on your hormone levels and your specific set of symptoms. This makes them far more effective than the synthetic HRT drugs that are currently on the market.

Tuesday, October 30, 2012

Vive Hormones Support A Healthy Heart

Dr. Enrique Jacome
In case you haven’t heard it yet, heart disease is the number one killer of women in the U.S. To put it in more concrete terms, 1100 women died of heart disease each day in 2011.

It’s a staggering number that means we need to look at what happens to increase the risk of heart disease in women as they age.It’s a simple connection between heart disease and menopause. Estrogen, the hormone women have an abundance before menopause, is a major protector of the heart and once that disappears, women catch up with men and even surpass them in having more heart attacks, strokes and cardiac disease.There are 52 million women over age 50 today who should run to get prescriptions for bioidentical hormones, which would immediately drop their risk of heart disease by more than 60 percent.

Let me explain why:

When we are in our 20s and 30s, we are full of hormones. By that I mean we are full of estradiol (estrogen of youth), progesterone (the hormone that balances estrogen) and yes, even testosterone. We are full of energy, want to have sex  and don’t have wrinkles. Our skin glows and weight loss is easy with diet and exercise. Hormones are the root reason we are healthy when we are young.  They also support our immune function so we get over a cold in 48 hours and eliminate inflammation so we don’t suffer with arthritic joints.

In our 40s, things change. We manufacture fewer hormones, ovulate irregularly and the quality diminishes until we stop making them altogether at menopause. On the outside, wrinkles appear, midriff bulge spills over, energy drops and sleep becomes a nightmare, accompanied by hot flashes, night sweats, palpitations and, of course, anxiety.

Inside, the loss of hormones increases bad-cholesterol levels, plaque in our arteries and shortness of breath.

Complicating the picture for women is the fact that they do not experience or manifest heart disease like men.

Chest pain may not be the presenting symptom. Heart disease in women can be a nagging toothache, jaw aches, arm pain and often exhaustion and persistent cough.

Too many women who die are misdiagnosed, because studies on and treatments for heart disease have been conducted with men.

If women would learn to be unafraid of bioidentical hormones – which are manufactured to look identical to their own hormones – and take them before menopause, heart disease would claim fewer women’s lives. Let’s start today, shall we?
  1. Become aware that hormones are your saviors and protectors.
  2. Start taking bioidentical hormones as soon as you begin experiencing symptoms of pre-menopause.
  3. If you have a family history of heart disease, start bioidentical hormones as early as possible.
  4. Change your diet to low carbs, low animal fat, high vegetable and fruit by age 40.
  5. Cut down on alcohol, caffeine, soda and sugar substitutes.
  6. Increase the amount of cardio exercise and strength building to 30 minutes a day.
  7. Sleep eight hours every night.
  8. Eliminate fear and anxiety from your life. They are dangerous to your heart.
  9. Work with doctors who support and encourage you, not fear-mongers.
  10. Don’t fear heart disease or cancer. Take control of your life and enjoy every minute. Stay young and full of hormones forever.

Tuesday, October 23, 2012

Study Shows Menopause Does Not Result In Weight Gain Overall - It Increases Belly Fat Specifically

Dr. Enrique Jacome
Menopause does not result in weight gain among women, however, hormonal adjustments are linked to a difference in fat distribution, which increases belly fat, according to a recent study that has been released by the International Menopause Society in light of the upcoming World Menopause Day on October 18th.

The new trial, published in Climacteric, is a comprehensive, scientifically based report on weight gain when a woman reaches menopause. 

Many women are bothered by the thought of gaining weight, and during middle-age years they begin to gain around 0.5kg or 1lb every year. Weight gain is of concern not only because women do not like to look overweight; it is associated with a several chronic diseases and conditions, such as hypertension (high blood pressure), depression, cardiovascular disease, diabetes and other medical conditions. 

Approximately 1.5 billion adults are overweight worldwide - 300 million of them are obese females. Since 1980, obesity rates have increased two-fold, mostly in industrialized nations. Experts say the obesity epidemic is caused by lifestyle changes, physical inactivity, and eating habits. A higher percentage of females are obese than males; probably because women are more susceptible to hormonal imbalances.

Experts examined findings regarding weight gain during menopause and discovered that surprisingly, increase in weight is due to non-hormonal factors, rather than the actual menopause.

The researchers found that the way fat is deposited during the menopause changes significantly; this is the main reason for rising obesity rates among women in this age group. Regardless of whether women gain weight when they hit middle-age years, they do undergo a change in the way fat accumulates in their bellies. 


www.vivenaturalhormones.com

Thursday, October 11, 2012

10 Year Study Finds Hormone Replacement Therapy Reduces Heart Attack And Heart Failure Risk Dramatically

Dr. Enrique Jacome
Women who receive Hormone Replacement Therapy soon after the menopause have a much lower risk of heart attack, heart failure or dying early compared to women of the same age who do not, Danish researchers reported in the BMJ. 
The team of researchers from Denmark carried out a 10-year long randomized trial, with an extra six years of follow-up to determine what impact HRT might have on cardiovascular risk if it were started soon after menopause.

They recruited 1,006 women and randomly selected them into two groups:

  • The HRT group - 504 women
  • The non-HRT group - 502 women
All the women were Caucasian, recently menopausal, aged between 45 and 58 years, and healthy. The researchers only included women who had had a hysterectomy if they were aged from 45 to 52. They did not include women with uncontrolled chronic diseases, a medical history of cancer, current or previous HRT use (within the last 3 months), bone disease, drugaddiction, or alcohol dependency.

The researchers used information on diagnoses or death from the Danish Civil Registration System and National Hospital Discharge Register. The primary end-point was a combo of death and hospitalization for heart failure or a heart attack.

After a decade of randomized treatment, the patients were advised to stop HRT after the results of the Women's Health Initiative and the Million Women Study were published.

During this ten year period:

  • In the HRT Group - there were 15 deaths and 16 deaths or cardiovascular end-points
  • In the non-HRT Group - there were 26 deaths and 33 deaths or cardiovascular end-points
The team followed-up on the women for a further six years. The primary end-point was seen in:
  • 33 women in the HRT group - 27 deaths, 3 heart failures, and 3 heart attacks
    Causes of death - 6 cardiovascular deaths and 21 non-cardiovascular deaths
  • 53 women in the non-HRT group - 40 deaths, 8 heart failures, and 5 heart attacks
    Causes of death - 23 cardiovascular deaths and 17 non-cardiovascular deaths

Thursday, October 4, 2012

Early Study Results: Hormone Replacement Therapy Lessens Menopause Symptoms Including Improvement Of Mood And Cardiovascular Risk Factors

Dr. Enrique Jacome
According to early results of a highly anticipated study that were presented at a meeting in the US on Wednesday, it appears that estrogen-progesterone hormone replacement therapy, if started soon after menopause, not only lessens many symptoms but also improves mood and some cardiovascular risk factors. 

While the findings are still preliminary and have yet to be submitted for peer review before publication in a journal, the researchers presented the early results of their HRT study at the North American Menopause Society's Annual Meeting, which is taking place in Orlando, Florida from Oct 3-6, 2012.

The study was designed and funded by the Kronos Longevity Research Institute to answer questions raised by the Women's Health Initiative (WHI), and is called KEEPS (short for Kronos Early Estrogen Prevention Study).


www.vivenaturalhormones.com

Wednesday, September 19, 2012

Study Shows Hormone Therapy May Ward Off Dementia In Women


Dr. Enrique Jacome
Research suggests that hormone therapy taken soon after menopause may help protect against the mental decline of dementia, even though it raises that risk in elderly women. The study adds yet another frustrating twist to the back-and-forth findings about whether hormone-replacement therapy protects against diseases of aging. Though the accepted answer has been "no" in recent years, the latest evidence suggests that timing of treatments may be key, at least for heart attacks and now for dementia.

"When you give it may be very important," said Dr. Sam Gandy, an Alzheimer's disease expert at Thomas Jefferson University in Philadelphia. The new findings were released Wednesday in Boston at a meeting of the American Academy of Neurology. Experts cautioned that they are preliminary. Lead researcher Dr. Victor Henderson, of Stanford University, agreed that it's too soon to consider putting younger women back on hormones to forestall dementia.

For decades, women routinely took hormones to treat the hot flashes of menopause and to ward off ailments of aging. Then, in 2002, a milestone study showed higher risks of heart attack, stroke, and breast cancer with estrogen-progestin treatments. Estrogen-only pills were later also linked to stroke.

As a result, millions of women gave up the pills, and government experts advised women to use them only for severe menopause symptoms and to take the lowest dose for the shortest time possible. But in recent weeks, mounting evidence has emerged that women who take such drugs closer to menopause may get more benefit or confront less risk than women who start taking them later. An analysis this month indicated the drugs do not raise the risk of heart attack for women ages 50-to-59, and they seem to survive longer with the drug.

The latest findings focused on 7,153 women in an offshoot study of the huge Women's Health Initiative that tracked breast cancer and heart disease. The cognitive study was funded by the National Institutes of Health and by Wyeth, which sells hormone treatments. Previous research showed that women who take hormones after age 65 experience a 75 percent increased risk of dementia over other women. But this study found the opposite for women who took hormones before age 65: Dementia risk was reduced by nearly half.

Dementia developed in 22 of 2,228 women -- or only 1 percent -- who took hormones at the earlier time, but in 84 of 4,925 who did not -- or 1.7 percent. The apparent protective effect was especially strong for Alzheimer's disease, a common form of dementia. "It's an intriguing and biologically plausible finding ... but it needs to be confirmed," said Dr. JoAnn Manson, of Brigham and Women's Hospital in Boston, who helped research the Women's Health Initiative. She said replacement hormones may preserve blood circulation in the brain.